<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.EmailStyle22
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal>Thanks, Roger. There’s something about that that just doesn’t sit well with me. How do they know that the difference between the near relatives is not the crucial difference. After all, deadly nightshade is a close relative of tomatoes. And what does malaria have to do with it … a completely different sort of organism. <o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Anyway, I like the dream. <o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Nick <o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Nicholas Thompson<o:p></o:p></p><p class=MsoNormal>Emeritus Professor of Ethology and Psychology<o:p></o:p></p><p class=MsoNormal>Clark University<o:p></o:p></p><p class=MsoNormal><a href="mailto:ThompNickSon2@gmail.com"><span style='color:#0563C1'>ThompNickSon2@gmail.com</span></a><o:p></o:p></p><p class=MsoNormal><a href="https://wordpress.clarku.edu/nthompson/"><span style='color:#0563C1'>https://wordpress.clarku.edu/nthompson/</span></a><o:p></o:p></p><p class=MsoNormal> <o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><div style='border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b>From:</b> Friam <friam-bounces@redfish.com> <b>On Behalf Of </b>Roger Critchlow<br><b>Sent:</b> Tuesday, April 28, 2020 1:21 PM<br><b>To:</b> The Friday Morning Applied Complexity Coffee Group <friam@redfish.com><br><b>Subject:</b> Re: [FRIAM] In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead - The New York Times<o:p></o:p></p></div><p class=MsoNormal><o:p> </o:p></p><div><p class=MsoNormal>They have a leg up because they already tested a close relative of their vaccine for safety. That's the first step in clinical trials, to prove that you do no harm. So they've modified that already tested vaccine for the current pandemic and they're ready to go directly to efficacy trials.<o:p></o:p></p><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>-- rec --<o:p></o:p></p></div></div><p class=MsoNormal><o:p> </o:p></p><div><div><p class=MsoNormal>On Tue, Apr 28, 2020 at 12:15 PM <<a href="mailto:thompnickson2@gmail.com">thompnickson2@gmail.com</a>> wrote:<o:p></o:p></p></div><blockquote style='border:none;border-left:solid #CCCCCC 1.0pt;padding:0in 0in 0in 6.0pt;margin-left:4.8pt;margin-right:0in'><div><div><p>Hi, all, <o:p></o:p></p><p>Can anybody explain the leg-up that Oxford group has because of their work on Malaria? <o:p></o:p></p><p><a href="https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html?action=click&module=Spotlight&pgtype=Homepage" target="_blank">https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html?action=click&module=Spotlight&pgtype=Homepage</a><o:p></o:p></p></div></div><p class=MsoNormal>.-. .- -. -.. --- -- -..-. -.. --- - ... -..-. .- -. -.. -..-. -.. .- ... .... . ...<br>FRIAM Applied Complexity Group listserv<br>Zoom Fridays 9:30a-12p Mtn GMT-6 <a href="http://bit.ly/virtualfriam" target="_blank">bit.ly/virtualfriam</a><br>unsubscribe <a href="http://redfish.com/mailman/listinfo/friam_redfish.com" target="_blank">http://redfish.com/mailman/listinfo/friam_redfish.com</a><br>archives: <a href="http://friam.471366.n2.nabble.com/" target="_blank">http://friam.471366.n2.nabble.com/</a><br>FRIAM-COMIC <a href="http://friam-comic.blogspot.com/" target="_blank">http://friam-comic.blogspot.com/</a> <o:p></o:p></p></blockquote></div></div></body></html>